Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Raetz

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate RandomizationStuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2020
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaKimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.
Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.
Nature Communications|November 27, 2019
Identification of four novel associations for B-cell acute lymphoblastic leukaemia riskJayaram Vijayakrishnan, Maoxiang Qian, James B Studd, et al.
Blood|June 28, 2014
HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergiesChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic LeukemiaChengcheng Liu, Wenjian Yang, Meenakshi Devidas, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Blood|January 7, 2018
Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemiaKaren L Bride, Tiffaney L Vincent, Soo-Yeon Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2018
Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate RandomizationStuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
JAMA Network Open|October 28, 2021
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid LeukemiaKelly D Getz, Julia E Szymczak, Yimei Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2020
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaKimberly P Dunsmore, Stuart S Winter, Meenakshi Devidas, et al.
Pediatric Blood & Cancer|March 9, 2019
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapyKatherine M Robinson, Wenjian Yang, Seth E Karol, et al.
Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.
Nature Communications|November 27, 2019
Identification of four novel associations for B-cell acute lymphoblastic leukaemia riskJayaram Vijayakrishnan, Maoxiang Qian, James B Studd, et al.
Blood|June 28, 2014
HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergiesChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic LeukemiaChengcheng Liu, Wenjian Yang, Meenakshi Devidas, et al.
Infection Control and Hospital Epidemiology|April 25, 2022
Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemiaCaitlin W Elgarten, William R Otto, Luke Shenton, et al.
Pageof 16